Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia
Peroxisome proliferator-activated receptor alpha (PPARA) has been suggested as a therapeutic target for chronic lymphocytic leukemia (CLL). However, the underlying molecular mechanism remains largely unclear. In this study, we analyzed DNA next-generation sequencing (NGS) data and clinical informati...
Main Authors: | Xixi Xiang, Fu Li, Sha Zhou, Yunjing Zeng, Xiaojuan Deng, Hongyang Zhang, Jiali Li, Hongyun Liu, Jun Rao, Lei Gao, Cheng Zhang, Qin Wen, Li Gao, Xi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2023-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2023/8456833 |
Similar Items
-
PB1954: PROGNOSTIC ANALYSIS OF GENE MUTATIONS ON TIME-TO-FIRST TREATMEN IN 93 NEWLY DIAGNOSED CHRONIC LYMPHOBLASTIC LEUKEMIA PATIENTS
by: Xixi Xiang, et al.
Published: (2023-08-01) -
PB2094: APPLICATION OF WHOLE-GENOME SEQUENCING FOR COPY NUMBER ABNORMALITY IN MULTIPLE MYELOMA
by: Jiali LI, et al.
Published: (2023-08-01) -
Mechanism of Action of the Plateau-Adapted Gene PPARA in COPD
by: Honge Li, et al.
Published: (2024-02-01) -
Chinese yellow cattle PPARA gene: Analyses of expression, polymorphism and trait association
by: Ningbo Chen, et al.
Published: (2018-12-01) -
MicroRNA-141 represses HBV replication by targeting PPARA.
by: Wei Hu, et al.
Published: (2012-01-01)